DNAJB6, a Key Factor in Neuronal Sensitivity to Amyloidogenesis.
Arun Thiruvalluvan1, Eduardo P de Mattos1, Jeanette F Brunsting1
1Department of Biomedical Sciences of Cells & Systems, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Molecular Cell
|April 9, 2020
Summary
Polyglutamine diseases like spinocerebellar ataxia and Huntington's disease show neuronal hypersensitivity. Stem cells are protected from protein aggregates due to chaperone DNAJB6 expression, which is lost during neuronal differentiation.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- CAG-repeat expansions in genes lead to neurodegenerative diseases.
- Polyglutamine proteins aggregate, causing neuronal toxicity despite ubiquitous expression.
Purpose of the Study:
- Investigate neuronal hypersensitivity to polyglutamine proteins.
- Understand the protective mechanisms in stem cells versus neurons.
Main Methods:
- Generated induced pluripotent stem cell (iPSC) lines from spinocerebellar ataxia type 3 and Huntington's disease patients.
- Differentiated iPSCs into neurons and neural progenitors.
- Analyzed protein aggregation and chaperone expression (DNAJB6) under glutamate treatment.
Main Results:
- iPSCs and neural progenitors did not form spontaneous aggregates.
- Glutamate treatment induced aggregation in neurons but not progenitors.
- Chaperone network rewiring occurred during differentiation, including loss of DNAJB6 expression.
- DNAJB6 upregulation in neurons reduced aggregation; its knockdown in progenitors caused aggregation.
Conclusions:
- Stem cells are intrinsically protected against polyglutamine aggregation.
- Loss of DNAJB6 expression during neuronal differentiation explains neuronal hypersensitivity.
- DNAJB6 plays a critical role in preventing polyglutamine-induced protein aggregation in neurons.
Related Concept Videos
03:03Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
03:03Amyloid Fibrils
6.2K
6.2K